PMCB insider buying and SEC filings, explained
PharmaCyte Biotech, Inc. · CIK 1157075
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- NV
- Fiscal year end
- Apr 30
- Former names
- NUVILEX, INC.; EFOODSAFETY COM INC
Insider activity in the last 12 months
Bought
$129K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jan 5–7, 2026 | Purchase (code P) | Joshua Silverman (CEO and Director) bought 100,000 shares between Jan 5 and Jan 7 at about $0.8030 ($80K), reported as a purchase (code P). Holdings up 32% to 416,250 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 7, 2026 |
| Jan 5–7, 2026 | Purchase (code P) | Jonathan Schechter (Director) bought 60,000 shares between Jan 5 and Jan 7 at about $0.8033 ($48K), reported as a purchase (code P). Holdings up 45% to 192,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 7, 2026 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$129K in purchases since Jan 7, 2026 · Purchases traded Jan 7, 2026 to Jan 7, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Jonathan Schechter (Director) | $48K | Jan 7, 2026 | SEC filing |
| Joshua Silverman (CEO) | $80K | Jan 7, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PMCB in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.